A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400 mg/Day Monotherapy in Subjects With Partial-onset Seizures

The objective of this historical-controlled trial is to demonstrate the efficacy and safety
of conversion to Lacosamide monotherapy in subjects with Partial-onset Seizures who are
withdrawn from 1 to 2 marketed antiepileptic drugs.

本历史性对照试验旨在验证：针对已停用1至2种已上市抗癫痫药物的部分性发作（Partial-onset Seizures）受试者，采用拉考沙胺（Lacosamide）单药治疗的疗效与安全性。